Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lew

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Implementation Science : IS|February 26, 2016
Partnering with health system operations leadership to develop a controlled implementation trialMark S Bauer, Christopher Miller, Bo Kim, et al.
Scientific Reports|January 6, 2026
A brief visual evoked potential (VEP) modulation assessment of experience-dependent plasticity recorded via wireless dry-EEG headset in Phase 1 clinical unitsEsther C McWilliams, Snezana M Milanovic, Torbjørn Elvsåshagen, et al.
Cardiovascular Radiation Medicine|August 2, 2003
Acute procedural complications and in-hospital events after percutaneous coronary interventions: eptifibatide versus abciximabAndrew E Ajani, Ron Waksman, Luis Gruberg, et al.
Medical Care|September 14, 2019
The Collaborative Chronic Care Model for Mental Health Conditions: From Evidence Synthesis to Policy Impact to Scale-up and SpreadMark S Bauer, Kendra Weaver, Bo Kim, et al.
International Journal of Cardiology|August 19, 2008
Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registryBryan P Yan, Andrew E Ajani, Gishel New, et al.
The American Journal of Cardiology|June 14, 2008
Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry)Bryan P Yan, Stephen J Duffy, David J Clark, et al.
Clinical Trials (London, England)|January 29, 2011
Challenges in the design and conduct of controlled clinical effectiveness trials in schizophreniaRobert A Rosenheck, John H Krystal, Robert Lew, et al.
Diabetes Care|February 17, 2007
The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomesLalita Khaodhiar, Thanh Dinh, Kevin T Schomacker, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2019
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D<sub>2</sub> Receptor Mechanism of ActionNina Dedic, Philip G Jones, Seth C Hopkins, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 30, 2007
An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registryBryan P Yan, Ronen Gurvitch, Stephen J Duffy, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Implementation Science : IS|February 26, 2016
Partnering with health system operations leadership to develop a controlled implementation trialMark S Bauer, Christopher Miller, Bo Kim, et al.
Scientific Reports|January 6, 2026
A brief visual evoked potential (VEP) modulation assessment of experience-dependent plasticity recorded via wireless dry-EEG headset in Phase 1 clinical unitsEsther C McWilliams, Snezana M Milanovic, Torbjørn Elvsåshagen, et al.
Cardiovascular Radiation Medicine|August 2, 2003
Acute procedural complications and in-hospital events after percutaneous coronary interventions: eptifibatide versus abciximabAndrew E Ajani, Ron Waksman, Luis Gruberg, et al.
Medical Care|September 14, 2019
The Collaborative Chronic Care Model for Mental Health Conditions: From Evidence Synthesis to Policy Impact to Scale-up and SpreadMark S Bauer, Kendra Weaver, Bo Kim, et al.
International Journal of Cardiology|August 19, 2008
Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registryBryan P Yan, Andrew E Ajani, Gishel New, et al.
The American Journal of Cardiology|June 14, 2008
Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry)Bryan P Yan, Stephen J Duffy, David J Clark, et al.
Clinical Trials (London, England)|January 29, 2011
Challenges in the design and conduct of controlled clinical effectiveness trials in schizophreniaRobert A Rosenheck, John H Krystal, Robert Lew, et al.
Diabetes Care|February 17, 2007
The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomesLalita Khaodhiar, Thanh Dinh, Kevin T Schomacker, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2019
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D<sub>2</sub> Receptor Mechanism of ActionNina Dedic, Philip G Jones, Seth C Hopkins, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 30, 2007
An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registryBryan P Yan, Ronen Gurvitch, Stephen J Duffy, et al.
Pageof 7